18 小时
Medpage Today on MSNLong-Acting ART Could Prevent More Infant HIV Infections in ZimbabweSAN FRANCISCO -- Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence ...
Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
The results of a groundbreaking trial carried out in Durban to find a cure for HIV are showing promise, scientists say.
Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...
When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.
The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...
El Mundo on MSN5 天
New advance against HIV: a single annual injection against the infectionData from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...
3 天
LGBTQ Nation on MSNOnce-a-year shot for HIV protection passes early safety trialAn annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果